ThinkSono enters Butterfly Garden, leveraging Butterfly Network’s software program improvement equipment (SDK) to build and deploy ThinkSono AI that will probably be suitable with Butterfly’s main imaging platform.
LONDON, UK / ACCESSWIRE / October 6, 2023 / – ThinkSono Ltd (“ThinkSono”) a number one Ultrasound AI firm, right this moment introduced it has joined Butterfly Garden, a synthetic intelligence (AI) Marketplace launched by Butterfly Network, Inc, (“Butterfly”) a digital well being firm remodeling care by means of the facility of transportable, semiconductor-based ultrasound know-how and intuitive software program.
Under this partnership, ThinkSono plans to build ThinkSono AI coaching options and ThinkSono Guidance, a deep vein thrombosis (DVT) medical answer to be used with Butterfly’s single-probe, whole-body handheld ultrasound system, topic to relevant approvals and authorizations. ThinkSono and Butterfly goal to allow healthcare practitioners to be taught a number of key point-of-care ultrasound scans, together with the detection of deep vein thrombosis (DVT).
Venous thromboembolism
Venous thromboembolism (VTE) is related to a significant international burden of illness. Worldwide, the incidence of VTE is 1-3 per 1000 people, rising to 2-7 per 1000 in people aged over 70 years, and 3-12 per 1000 in these over 80 years. VTE, deep vein thrombosis (DVT) and pulmonary embolus (PE) are the main reason behind hospital-related disability-adjusted life years misplaced.
Using these estimates, and utilizing essentially the most conservative incidence determine, globally at the least 7.7 million folks would require investigation for VTE yearly. An ageing inhabitants throughout many nations will result in a better well being burden, notably in middle- and low-income nations the place early dying from an infection is reducing.
Mortality from VTE is widespread, a European research estimated 534,000 deaths per 12 months and the same research within the US reported 300,000 deaths per 12 months. DVT has a excessive stage of morbidity. 30-50% of the surviving sufferers develop long-term signs of their affected leg (post-thrombotic syndrome).1
Opportunity for the Future
In August 2023, Butterfly Network launched Butterfly Garden, permitting third-party builders access to its proprietary SDK and APIs to build new AI purposes that work at the side of Butterfly’s imaging platform, bringing with it access to their outstanding point-of-care ultrasound buyer base. ThinkSono, with its real-time ultrasound AI capabilities, was a perfect match for this system.
Fouad Al Noor, CEO and Co-Founder of ThinkSono commented, “We are vastly excited to deploy ThinkSono’s real-time AI software program on Butterfly’s platform because of the intensive attain, real-time ultrasound streaming capabilities and integration with your entire Butterfly ecosystem. Butterfly has the biggest group of handheld POCUS customers worldwide, and so it was a pure alternative for us to hunt to companion with them.”
Darius Shahida, Butterfly Network’s Chief Strategy Officer & Chief Business Development Officer, added, “We are excited to welcome ThinkSono to the Butterfly Garden. Their progressive AI and know-how are nice early examples of the varieties of instruments we hope to carry to our group of customers by means of Butterfly Garden – a premier vacation spot for AI in ultrasound.”
About ThinkSono
Founded in 2016, ThinkSono (www.thinksono.com) has developed the world’s first real-time Ultrasound AI software program to allow non-ultrasound healthcare employees to carry out DVT scans. This know-how addresses the worldwide unmet medical want for higher DVT detection.
Furthermore, ThinkSono is growing coaching options for different ultrasound AI purposes which goals to extend access to ultrasound imaging and upskilling non-ultrasound educated healthcare employees to carry out key ultrasound scans. ThinkSono’s DVT answer has already been trialed in hospitals throughout the UK, EU and is now increasing into the U.S.
With a number of patents granted and a number of peer-reviewed papers printed in outstanding journals equivalent to Nature Digital Medicine, ThinkSono has demonstrated its management within the Ultrasound AI area. The firm goals to allow any healthcare skilled to make use of the facility of ultrasound to diagnose illness and improve the common access to ultrasound imaging.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011 and listed on the New York Stock Exchange by means of a business mixture with Longview Acquisition Corp., Butterfly created the world’s first handheld, single probe whole-body ultrasound system utilizing semiconductor know-how, the Butterfly iQ+. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration of world well being fairness, making high-quality ultrasound inexpensive, easy-to-use, globally accessible, and intelligently related, together with for the 4.7 billion folks all over the world missing access to ultrasound. Through its proprietary Ultrasound-on-Chip™ know-how, Butterfly is paving the way in which for earlier detection and distant administration of well being circumstances all over the world. The Butterfly iQ+ will be bought right this moment by educated healthcare practitioners in areas together with, however not restricted to, components of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to be taught extra about available nations, go to: www.butterflynetwork.com/choose-your-country.
Citations
-
Kainz, B., Heinrich, M.P., Makropoulos, A. et al. Non-invasive analysis of deep vein thrombosis from ultrasound imaging with machine studying. npj Digit. Med. 4, 137 (2021). https://doi.org/10.1038/s41746-021-00503-7
Contact Information
For Butterfly Business Inquiries: Darius Shahida
Chief Strategy & Business Development Officer, Butterfly
[email protected]
Butterfly Media: Liz Snyder
Head of Corporate Communications, Butterfly
[email protected]
For ThinkSono Inquiries:
[email protected]
SOURCE: ThinkSono Ltd
